Harbor Diversified Inc

OTC: HRBR    
Share price (4/26/24): $1.76    
Market cap (4/26/24): $96.5 million

Articles of Incorporation Filter

EX-3.3
from 10-K 30 pages Amended and Restated Bylaws of Harbor Diversified, Inc
12/34/56
EX-3.2
from 10-K 16 pages Certificate of Designations, Preferences and Rights of Series C Convertible Redeemable Preferred Stock of Harbor Diversified, Inc. Pursuant to Sections 103 and 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 10-K 19 pages Amended and Restated Certificate of Incorporation of Harbor Diversified, Inc. (As Amended Through December 31, 2019) * * *
12/34/56
EX-3.3
from 10-Q 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Harbor Biosciences, Inc., a Delaware Corporation
12/34/56
EX-3.2
from 10-Q 2 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of Harbor Biosciences, Inc., a Delaware Corporation
12/34/56
EX-3.1
from 10-Q 20 pages Amended and Restated Certificate of Incorporation of Harbor Biosciences, Inc
12/34/56
EX-3.2
from 8-K 30 pages Amended and Restated Bylaws of Harbor Biosciences, Inc
12/34/56
EX-3.2
from DEFA14A 30 pages Amended and Restated Bylaws of Harbor Biosciences, Inc
12/34/56
EX-3.1
from 8-K 7 pages Certificate of Designations, Preferences and Rights of Series a Preferred Stock of Harbor Biosciences, Inc. Pursuant to Sections 103 and 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from DEFA14A 7 pages Certificate of Designations, Preferences and Rights of Series a Preferred Stock of Harbor Biosciences, Inc. Pursuant to Sections 103 and 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Amended and Restated Certificate of Incorporation of Harbor Biosciences, Inc., a Delaware Corporation
12/34/56
EX-3.2
from 10-K 31 pages Bylaws of Harbor Biosciences, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Ownership Merging H.E. Acquisition Corp., a Delaware Corporation Into Hollis-Eden Pharmaceuticals, Inc., a Delaware Corporation
12/34/56
EX-3.5
from 8-K 1 page Amendment to Bylaws of Hollis-Eden Pharmaceuticals, Inc
12/34/56
EX-3.02
from 8-K 31 pages Bylaws of Hollis-Eden Pharmaceuticals, Inc
12/34/56
EX-3.4
from 10-Q 1 page Certificate of Amendment
12/34/56
EX-3
from SC 13G 1 page <page> Page 12 of 12 Exhibit C Identification and Classification of Subsidiary Which Acquired Security Being Reported on by the Parent Holding Company Ssim, a Registered Investment Adviser, Acquired "Beneficial Ownership" of the Securities Being Reported on as a Result of Its Discretionary Authority to Acquire, Dispose and (With Respect to Certain of Such Securities) Vote the Securities Being Reported On. Under a Series of SEC No-Action Letters, Including the Letter Issued to Warren Buffet and Berkshire Hathaway, Inc. (Available December 18, 1987), Ssco and Strome Are Each Considered the Equivalent of a Parent Holding Company of Ssim and Are Therefore Eligible to Report Their Indirect Beneficial Ownership in Such Shares on Schedule 13g
12/34/56